Indonesia vs Yemen: Access to anti-retroviral drugs, female
Indonesia
36.0%
in 2024
Yemen
34.0%
in 2024
Indonesia rank
130th
Yemen rank
132nd
Access to anti-retroviral drugs, female over time
- Indonesia
- Yemen
How they compare
Indonesia currently reports 36.0% against 34.0% in Yemen, a difference of 2.0%.
That makes Indonesia's figure about 1.1 times Yemen's.
The two have swapped places 3 times across 25 shared years of data; in 2000 it was Yemen ahead.
Indonesia ranks 130th and Yemen ranks 132nd of 141 countries.
Across the 3 decades both report, Indonesia averaged higher in 1 and Yemen in 2.
Head to head by decade
| Decade | Indonesia | Yemen | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 1.3% | 1.1% | 0.2% | Indonesia |
| 2010s | 12.9% | 18.5% | 5.6% | Yemen |
| 2020s | 28.8% | 31.2% | 2.4% | Yemen |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Indonesia or Yemen?
- Indonesia, at 36.0% against 34.0% in Yemen as of 2024.
- What is the difference in access to anti-retroviral drugs, female between Indonesia and Yemen?
- 2.0%, with Indonesia ahead.
- How many years of comparable data are there for Indonesia and Yemen?
- 25 years are reported by both, from 2000 to 2024.
- How do Indonesia and Yemen rank globally for access to anti-retroviral drugs, female?
- Indonesia ranks 130th and Yemen ranks 132nd of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.